We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Counts of MRSA, MSSA, Gram-negative bacteraemia and C. difficile infection bi-annually reported by independent sector organisations, with accompanying commentary.
Mandatory Surveillance of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia: April 2023 to April 2024
Counts and rates of MRSA, MSSA, E. coli, P. aeruginosa, Klebsiella spp. bacteraemia and C. difficile infection reported by independent sector healthcare organisations, with accompanying commentary.
Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.
Surveillance of healthcare-associated infections (HCAI); MRSA, MSSA and Gram-negative bacteremia (Escherichia coli (E.coli), Pseudomonas aeruginosa ( P. aeruginosa), Klebsiella species ( Klebsiella spp.), and Clostridioides difficile ( C.difficile) infection among Independent Sector providers. Experimental statistics for the period April 2021...
Deaths where meticillin-resistant Staphylococcus aureus (MSA) was mentioned on the death certificate: by sex, age group and place of death, in England and Wales. National data are available from 1993 onwards.
Mandatory surveillance of healthcare associated infections (HCAI); MRSA, MSSA and Gram-negative bacteraemia (Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Klebsiella species (Klebsiella. spp.), and Clostridioides difficile (C. difficile) infection. Annual data and epidemiological commentary for the financial year April...
Epidemiological analyses of mandatory surveillance data on healthcare associated infections (HCAI); MRSA, MSSA and Gram-negative bacteraemia (Escherichia coli (E. coli), Pseudomonas aeruginosa ( P. aeruginoa), Klebsiella species (Klebsiella spp.)), and Clostridioides difficile (C. difficile) infection.
Mandatory Surveillance of MRSA, MSSA and Gram-negative bacteraemia and Clostridioides difficile infection: November 2020 to November 2021
This bulletin presents the latest figures on deaths mentioning either Clostridium difficile infection or Meticillin-resistant Staphylococcus aureus (MRSA). Figures are presented for Wales and are broken down by sex, age group and whether the death occurred in hospital or elsewhere.
Mandatory Surveillance of MRSA, MSSA, and Escherichia coli bacteraemia and Clostridium difficile infection.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).